Nivolumab Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV)

Available Strengths: 40 mg/4 mL (vial); 100 mg/10 mL (vial)

Reference Brands: Opdivo® (EU & US)

Category: Oncology Cancer Care

Nivolumab is available in Intravenous (IV) and strengths such as 40 mg/4 mL (vial); 100 mg/10 mL (vial). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nivolumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Nivolumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Nivolumab (brand name Opdivo®) is a monoclonal antibody used in oncology as an immune checkpoint inhibitor. It works by targeting and blocking the PD-1 receptor on T-cells, which prevents cancer cells from evading the immune system. By doing so, Nivolumab enhances the body's immune response, allowing T-cells to identify and attack cancer cells more effectively. Nivolumab is indicated for the treatment of several cancers, including melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), head and neck squamous cell carcinoma, classical Hodgkin lymphoma, and others. It is administered as an intravenous (IV) infusion in two available strengths: 40 mg/4 mL and 100 mg/10 mL.